Supplementary Material - Treatment of alopecia areata of the beard with baricitinib

NIAID Data Ecosystem2026-03-14 收录

斑秃药物治疗

胡须斑秃临床案例

数据链接：

https://data.mendeley.com/datasets/d73ghdzrjs 数据链接链接失效反馈

官方服务：

资源简介：

28-year-old man with alopecia areata of the beard before and after 6 months of treatment with baricitinib.

创建时间：

2022-11-17

An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch Type Alopecia Areata, Totalis and Universalis. An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch Type Alopecia Areata, Totalis and Universalis

斑秃药物治疗

基因表达生物标记

This study was an open-label, clinical trial to investigate tofacitinib 5 mg to 10 mg PO twice daily in the treatment of moderate/severe alopeica areata and to identify if gene expression of the scalp

NIAID Data Ecosystem70

Supplemental Material: Real-world efficacy of ritlecitinib in treating alopecia areata across various anatomical sites: Potential rapid response predictors

斑秃药物治疗

真实世界证据

This real-world study aimed to evaluate the effectiveness and safety of ritlecitinib in a heterogeneous cohort of AA patients and identify response in scalp as well as lashes, brows and nails, and cli

Mendeley Data20

Supplement table for "Factors predicting response to Oral Methylprednisolone Tapering Treatment in Alopecia Areata: A retrospective study"

斑秃药物治疗

临床预测模型

Supplement Table 1. Characteristics of the Study Patients

Mendeley Data00

Efficacy and safety of compound glycyrrhizin in patients with alopecia areata: a systematic review and meta-analysis

斑秃药物治疗

临床疗效荟萃分析

Although compound glycyrrhizin (CG) has been widely used to alopecia areata (AA) in China, its efficacy and safety remain unclear. This systematic review and meta-analysis aimed to evaluate the effica

Taylor & Francis Group2025-12-21 更新30

Ritlecitinib in Alopecia Areata: A Multicenter Retrospective Real-World Analysis

斑秃药物治疗

真实世界证据

Supplemental Figure 1 detailing the SALT score changes before and after treatment discontinuation in 11 patients. Supplemental Table 1 detailing the demographic characteristics of all patients and Sup

NIAID Data Ecosystem00

Supplementary Material - Treatment of alopecia areata of the beard with baricitinib

资源简介：

相关数据集